ASTS 13th Annual Surgical Fellows Symposium Highlights

Group Photo_FS2019 3

The 13th Annual Surgical Fellows Symposium brought together second-year transplant surgery fellows and select ASTS members for an educational symposium on October 4-6, 2019, at The Luxor Hotel in Las Vegas, Nevada.

The meeting started with sessions focused on the selection of living donors, deceased donors, offers and outcomes, and technical discussions. Dr. Lloyd Ratner presented on the arc of change of the individual as part of his series of presidential addresses. He discussed how fellows are starting on the arc of their career and the abundance of opportunities they will have to make a difference in the years ahead.

Lloyd Fellows Symposium

On Saturday, fellows learned about burnout prevention strategies and how to transition from fellowship to practice. Everyone enjoyed a long afternoon break from the sessions to explore Las Vegas before the day concluded with presentations on the technical pitfalls of kidney, liver, and pancreas transplantation. On Sunday, fellows had the opportunity to participate in a jeopardy game and the day concluded with learning about the transplant surgery certification pathway and a discussion on the opportunities for improvement for fellowship training.

ASTS partnered with UNOS to conduct an “Offer Simulation Study to Examine the Role of Tailored Education on Kidney Offer Acceptance Decision-Making for 2nd Year Transplant Surgical Fellows.” Fellows and Faculty were asked to participate and complete a consent survey. All participants who accepted were sent offers in early September and the results were presented by Darren Stewart (UNOS) at the Fellows Symposium.

Thank You

Thank you to the Fellowship Training Committee, led by Dr. Andre Dick and Dr. Tayyab Diwan, for planning another successful symposium.

ASTS is grateful for the support received by our corporate partners. Thank you to:

CareDx, Platinum Level
Novartis Pharmaceuticals Corporation, Gold Level
Sanofi-Genzyme, Gold Level
CSL Behring, Silver Level
Veloxis Pharmaceuticals, Silver Level